Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/04/041571
CTRI/2022/04/041571
Not yet recruiting
Phase 2

A comparative clinical study on the efficacy of Dawa-e-Bars and Safoof-e Bars in Bars (Vitiligo)

Rajiv Gandhi University Of Health Sciences0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L80- Vitiligo

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L80- Vitiligo
Sponsor
Rajiv Gandhi University Of Health Sciences
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Subjects of Non\-Segmental vitiligo (Acrofacial, focal and Generalized) of any sex
  • •Subjects with Chronicity of less than 3 years
  • •Subjects with less or equal to 2 percent Body surface Area (BSA)
  • •Subjects fulfilling the Vitiligo Extent Tensity Index (VETI) score up to grade of tensity \+3
  • •Subjects who have not taken any treatment within the last 2 weeks

Exclusion Criteria

  • •Patients aged less than18 years or greater than 60 years.
  • •Patients with Segmental Vitiligo, Lip\-Tip, Universal Vitiligo, Mucosal Vitiligo.
  • •Patients with History of photosensitivity, photo exaggerated dermatoses and Connective Tissue Diseases.
  • •Pregnant or Lactating Women.
  • •Known cases of Cardiovascular, Endocrine, Pulmonary, Hepato\-renal Dysfunction.
  • •Known cases of Immunocompromised states like HIV AIDS, Malignancies
  • •Patients not willing to attend treatment schedule regularly.
  • •Patients suffering from cutaneous disorders like alopecia areata, halo nevus, Pityriasis alba, Malignant melanoma and Morphea.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
A clinical trial to study the effects of 2 formulations, Darvi rasakriya and Yashtimadhu rasakriya in the treatment of Mukhapaka (Aphthous stomatitis)
CTRI/2022/05/042947Balan R
Not yet recruiting
Phase 2
Comparing the therapeutic effects of special kind of laser to excise the white patch with tumeric tablets given & without tumeric tablets in managing the white lesioHealth Condition 1: R99- Ill-defined and unknown cause of mortalityHealth Condition 2: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue
CTRI/2023/09/057780SOWMIYA
Not yet recruiting
Phase 2
Effect of ayurvedic medicine drvyadi rasakriya in diabetes
CTRI/2023/01/049263Aushadhi Bhavan
Recruiting
Phase 2
The reduction in the number of attacks in multiple sclerosis patientsMultiple sclerosis patients.Multiple sclerosis
IRCT20190121042439N1Mashhad University of Medical Sciences40
Not yet recruiting
Not Applicable
The effectiveness of domperidone on preventing gastric residual volume in patients admitted to the intensive care unit
IRCT20220508054780N5Mashhad University of Medical Sciences60